— Know what they know.
/
Not Investment Advice

PRVB NASDAQ

Provention Bio, Inc.
1W: +3.0% 1M: +4.3% 3M: +186.8% 1Y: +396.6% 3Y: +113.1%
$24.98
Last traded 2023-04-27 — delisted
NASDAQ · Healthcare · Biotechnology · $2.4B mcap · 70M float · 4.08% daily turnover
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest Supply Chain

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2023-03-09
Earliest Filing
2023-03-09
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named PRVB in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
MGNX MACROGENICS INC partner Original counterparty to the Asset Purchase Agreement under which the TZIELD royalty interest was held by MacroGenics, I 2023-03-09 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms